EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
+0.6%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-3.8%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-6.87%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
80
New
27
Increased
6
Reduced
11
Closed
28
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$5.2M |
| 2 |
Amgen
AMGN
|
$3.69M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$2.94M |
| 4 |
AUTL
Autolus Therapeutics
AUTL
|
$2.92M |
| 5 |
Disc Medicine
IRON
|
$2.75M |
Top Sells
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$4.64M |
| 2 |
Dr. Reddy's Laboratories
RDY
|
$3.79M |
| 3 |
Avidity Biosciences
RNA
|
$3.45M |
| 4 |
Celldex Therapeutics
CLDX
|
$2.98M |
| 5 |
Geron
GERN
|
$2.93M |
Sector Composition
| 1 | Healthcare | 100% |